ペット糖尿病ケアの世界市場レポート2025年

ペット糖尿病ケア市場規模は、今後数年間で力強い成長が見込まれます。2029年には34億6,000万米ドルに成長し、CAGRは9.5％となります。予測期間の成長は、ペット保険導入の増加、カスタマイズ型糖尿病管理プラン、予防ペットヘルスケアへの注力、ペット健康動向のグローバリゼーション、ペットヘルスケア研究への投資の増加、消費者の豊かさの上昇に起因すると考えられます。予測期間の主要動向には、動物用診断の進歩、ペットの肥満管理への注力、インスリン送達システムの革新、ペット保険適用率の上昇、特殊ペットフードの入手可能性の増加、遠隔医療と遠隔モニタリング、動物医療における共同研究が含まれます。

今後5年間の成長率9.5％という予測は、前回の予測から0.1％の微減を反映しています。この減少は主に米国と他国との間の関税の影響によるものです。輸入グルコースモニタリング技術やインスリン送達システムに影響を及ぼす関税は、機器価格を引き上げ、ペットの慢性疾患管理を複雑にする可能性があります。また、相互関税や、貿易の緊張と制限の高まりによる世界経済と貿易への悪影響により、その影響はより広範囲に及ぶと考えられます。

ペット糖尿病ケア市場は、ペットの養子縁組の増加により成長すると予測されます。ペットの養子縁組とは、保護施設やレスキュー施設から動物を家庭に迎え入れることを指し、ブリーダーや店舗からペットを購入するよりも一般的になりつつあります。ペットの糖尿病の年間診断数は増加しており、その主要原因は、座りっぱなしの行動と加工食品の多い食事を特徴とするライフスタイルの類似性です。例えば、オーストラリアに本部を置く非政府組織であるAnimal Medicines Australiaは、2022年にペットの所有者数が2万8,730.8人に達し、2021年の39％から顕著に増加していると報告しています。これは24％の増加であり、ペットの飼育とペットケアへの投資の強い増加傾向を示しています。ペット飼育の増加は、オーストラリアの家庭におけるペットの人気の高まりを裏付けています。したがって、ペット飼育の増加がペット糖尿病ケア市場の成長を牽引しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、貿易戦争と関税、コロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界のペット糖尿病ケア：PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のペット糖尿病ケア市場：成長率分析
• 世界のペット糖尿病ケア市場の実績：規模と成長、2019～2024年
• 世界のペット糖尿病ケア市場の予測：規模と成長、2024～2029年、2034年
• 世界のペット糖尿病ケア：総潜在市場規模（TAM）

第6章 市場セグメンテーション

• 世界のペット糖尿病ケア市場：薬剤タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• インスリン療法
• 経口薬
• 世界のペット糖尿病ケア市場：デバイスタイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 血糖モニタリング装置
• インスリン送達デバイス
• 世界のペット糖尿病ケア市場：動物タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 犬
• ネコ
• その他の動物タイプ
• 世界のペット糖尿病ケア市場：エンドユーザー別、実績と予測、2019～2024年、2024～2029年、2034年
• 獣医クリニック
• 在宅ケア
• 動物病院
• 世界のペット糖尿病ケア市場、インスリン療法のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 犬用インスリン製品
• 猫用インスリン製品
• インスリン送達デバイス
• 世界のペット糖尿病ケア市場、経口薬剤のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• グリピジド
• メトホルミン
• その他の経口血糖降下剤

第7章 地域別・国別分析

• 世界のペット糖尿病ケア市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界のペット糖尿病ケア市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• ペット糖尿病ケア市場：競合情勢
• ペット糖尿病ケア市場：企業プロファイル
  • C.H. Boehringer Sohn AG & Co. KG
  • Becton Dickinson and Company
  • Merck & Co Inc.
  • Zoetis Inc.
  • Trividia Health Inc.

第31章 その他の大手企業と革新的企業

• Allison Medical Inc.
• UltiMed Inc.
• Apotex Inc.
• Henry Schein VET GmbH
• Medtrust Holdings Inc.
• i-SENS Inc.
• Taidoc Technology Corp.
• Covetrus Inc.
• ALR Technologies Inc.
• Vet Innovations Inc.
• F. Hoffmann-La Roche Ltd.
• Abbott Laboratories
• AgaMatrix Inc.
• Ascensia Diabetes Care Holdings AG
• Bayer AG

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、戦略

• ペット糖尿病ケア市場、2029年：新たな機会を提供する国
• ペット糖尿病ケア市場、2029年：新たな機会を提供するセグメント
• ペット糖尿病ケア市場、2029年：成長戦略
  • 市場動向による戦略
  • 競合の戦略

第36章 付録

Pet diabetes care addresses diabetes in pets, a condition that can lead to additional health issues such as heart disease, pancreatitis, urinary tract infections, kidney disease, and skin infections. Diabetes in pets arises from insufficient insulin production, its complete absence, or improper utilization, hindering the conversion of food into energy within their bodies.

The primary drug types within pet diabetes care comprise insulin therapy and oral medication. Insulin therapy aims to elevate peripheral glucose intake while reducing hepatic glucose synthesis, thereby regulating blood glucose levels in pets. Devices utilized for pet diabetes care encompass glucose monitoring devices and insulin delivery systems. These care measures cater to various animals such as canines, felines, and other species, implemented across veterinary clinics, home care settings, and veterinary hospitals.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The rapid escalation of U.S. tariffs and the resulting trade tensions in spring 2025 are having a considerable impact on the veterinary healthcare sector, particularly in the supply of pharmaceuticals, medical devices, and animal care products. Increased duties on imported veterinary medicines, diagnostic equipment, surgical tools, and pet care supplies have driven up operational costs for veterinary clinics, animal hospitals, and livestock health providers, forcing them to either raise service charges or absorb reduced profit margins. The livestock and agricultural industries are facing similar pressures, as tariffs on feed additives, vaccines, and breeding equipment push up production costs and complicate animal health management. Furthermore, retaliatory tariffs in major export markets have weakened demand for U.S.-manufactured veterinary products, adding to revenue challenges. To navigate these headwinds, the sector must now focus on local sourcing, preventive healthcare strategies, and digital veterinary solutions to control costs while continuing to deliver quality animal care.

The pet diabetes care market research report is one of a series of new reports from The Business Research Company that provides pet diabetes care market statistics, including pet diabetes care industry global market size, regional shares, competitors with an pet diabetes care market share, detailed pet diabetes care market segments, market trends and opportunities, and any further data you may need to thrive in the pet diabetes care industry. This pet diabetes care market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pet diabetes care market size has grown strongly in recent years. It will grow from $2.21 billion in 2024 to $2.4 billion in 2025 at a compound annual growth rate (CAGR) of 8.6%. The growth in the historic period can be attributed to growing awareness of pet health, advancements in veterinary medicine, prevalence of diabetes in pets, humanization of pets, increased focus on pet nutrition, awareness campaigns by veterinary organizations, availability of insulin and medications.

The pet diabetes care market size is expected to see strong growth in the next few years. It will grow to $3.46 billion in 2029 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to rise in pet insurance adoption, customized diabetes management plans, focus on preventive pet healthcare, globalization of pet health trends, increasing investments in pet healthcare research, rising consumer affluence. Major trends in the forecast period include advancements in veterinary diagnostics, focus on pet obesity management, innovation in insulin delivery systems, rise in pet insurance coverage, increased availability of specialized pet foods:, telemedicine and remote monitoring, collaborations in veterinary medicine.

The forecast of 9.5% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariffs affecting imported glucose monitoring technologies and insulin delivery systems may raise device prices and complicate chronic disease management in pets. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The pet diabetes care market is anticipated to grow due to a rise in pet adoption. Pet adoption refers to bringing animals from shelters or rescues into homes, which is becoming more common than purchasing pets from breeders or stores. The annual diagnosis of diabetes in pets is increasing, largely due to lifestyle similarities characterized by sedentary behavior and a diet high in processed foods. For instance, in 2022, Animal Medicines Australia, a non-governmental organization based in Australia, reported a notable increase in pet ownership, with the number of pet owners reaching 28,730.8 in 2022, compared to 39% in 2021. This represents a 24% rise, indicating a strong upward trend in pet adoption and investment in pet care. The increase in pet ownership underscores the growing popularity of pets in Australian households. Therefore, the rise in pet adoption is driving growth in the pet diabetes care market.

The increasing demand for pet insurance is expected to propel the growth of the pet diabetes care market in the future. Pet insurance provides financial protection that covers a portion of the veterinary expenses associated with pet care, helping pet owners manage the costs related to their pets' healthcare needs. This insurance typically covers the diagnosis, treatment, and management of diabetes, influenced by factors such as the pet's age, breed, and location. For example, in May 2023, the North American Pet Health Insurance Association (NAPHIA), a U.S.-based health insurance organization, reported that 5.36 million pets were insured in North America in 2022, reflecting a 21.7% increase from the 4.4 million insured in 2021. Consequently, the rising demand for pet insurance is contributing to the growth of the pet diabetes care market.

Increased research and development efforts, along with the introduction of new products, are key trends gaining traction in the pet diabetes market. Various studies are underway to better understand diabetes in animals and simplify its management. Additionally, companies are launching new offerings, such as generic drugs, to maintain their competitive edge in the market. In December 2022, the U.S. Food and Drug Administration (FDA), a scientific regulatory agency, approved a medication from Elanco Animal Health Inc. for cats suffering from a specific type of diabetes, marking it as the first oral medication authorized for this condition in animals.

Leading companies in the pet diabetes care market are concentrating on developing innovative technological products, such as the Petrackr diabetes monitoring device, to deliver reliable services to customers. The Petrackr diabetes monitoring device is a veterinary blood glucometer designed to monitor diabetes in cats and dogs. For instance, in May 2023, Universal Biosensors Inc., an Australia-based biosensor company, introduced the Petrackr diabetes monitoring device. This device provides blood glucose test results in just seconds and is user-friendly for both pet parents and veterinary clinicians. It is compatible with the Petrackr app, enabling users to easily record, monitor, and report their results.

In September 2022, Zoetis, a US-based animal health company, acquired Jurox for an undisclosed amount. With this acquisition, Zoetis aims to broaden the company's line of animal health products and provide opportunities to accelerate international growth by expanding its portfolio of animal parasiticides and anti-infectives. Jurox is an Australia-based veterinary pharmaceutical manufacturer that provides medicines for pets with diabetes.

Major companies operating in the pet diabetes care market are C.H. Boehringer Sohn AG & Co. KG, Becton Dickinson and Company, Merck & Co Inc., Zoetis Inc., Trividia Health Inc., Allison Medical Inc., UltiMed Inc., Apotex Inc., Henry Schein VET GmbH, Medtrust Holdings Inc., i-SENS Inc., Taidoc Technology Corp., Covetrus Inc., ALR Technologies Inc., Vet Innovations Inc., F. Hoffmann-La Roche Ltd., Abbott Laboratories, AgaMatrix Inc., Ascensia Diabetes Care Holdings AG, Bayer AG, Dexcom Inc., LifeScan Inc., Medtronic PLC, Novo Nordisk A/S, Sanofi S.A., Senseonics Holdings Inc., Tandem Diabetes Care Inc., Terumo Corporation, Animas Corporation, Insulet Corporation, Roche Diabetes Care Inc.

North America was the largest region in the pet diabetes care market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pet diabetes care market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the pet diabetes care market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pet diabetes care market includes revenues earned by entities by insulin therapy and insulin delivery devices. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pet Diabetes Care Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pet diabetes care market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pet diabetes care ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pet diabetes care market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Drug Type: Insulin Therapy; Oral Medication
• 2) By Device Type: Glucose Monitoring Devices; Insulin Delivery Devices
• 3) By Animal Type: Canine; Feline; Other Animal Types
• 4) By End-User: Veterinary Clinics; Home Care Settings; Veterinary Hospitals
• Subsegments:
• 1) By Insulin Therapy: Canine Insulin Products; Feline Insulin Products; Insulin Delivery Devices
• 2) By Oral Medication: Glipizide; Metformin; Other Oral Hypoglycemic Agents
• Companies Mentioned: C.H. Boehringer Sohn AG & Co. KG; Becton Dickinson and Company; Merck & Co Inc.; Zoetis Inc.; Trividia Health Inc.; Allison Medical Inc.; UltiMed Inc.; Apotex Inc.; Henry Schein VET GmbH; Medtrust Holdings Inc.; i-SENS Inc.; Taidoc Technology Corp.; Covetrus Inc.; ALR Technologies Inc.; Vet Innovations Inc.; F. Hoffmann-La Roche Ltd.; Abbott Laboratories; AgaMatrix Inc.; Ascensia Diabetes Care Holdings AG; Bayer AG; Dexcom Inc.; LifeScan Inc.; Medtronic PLC; Novo Nordisk A/S; Sanofi S.A.; Senseonics Holdings Inc.; Tandem Diabetes Care Inc.; Terumo Corporation; Animas Corporation; Insulet Corporation; Roche Diabetes Care Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Pet Diabetes Care Market Characteristics

3. Pet Diabetes Care Market Trends And Strategies

4. Pet Diabetes Care Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Pet Diabetes Care Growth Analysis And Strategic Analysis Framework

• 5.1. Global Pet Diabetes Care PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Pet Diabetes Care Market Growth Rate Analysis
• 5.4. Global Pet Diabetes Care Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Pet Diabetes Care Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Pet Diabetes Care Total Addressable Market (TAM)

6. Pet Diabetes Care Market Segmentation

• 6.1. Global Pet Diabetes Care Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Insulin Therapy
• Oral Medication
• 6.2. Global Pet Diabetes Care Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Glucose Monitoring Devices
• Insulin Delivery Devices
• 6.3. Global Pet Diabetes Care Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Canine
• Feline
• Other Animal Types
• 6.4. Global Pet Diabetes Care Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Veterinary Clinics
• Home Care Settings
• Veterinary Hospitals
• 6.5. Global Pet Diabetes Care Market, Sub-Segmentation Of Insulin Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Canine Insulin Products
• Feline Insulin Products
• Insulin Delivery Devices
• 6.6. Global Pet Diabetes Care Market, Sub-Segmentation Of Oral Medication, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Glipizide
• Metformin
• Other Oral Hypoglycemic Agents

7. Pet Diabetes Care Market Regional And Country Analysis

• 7.1. Global Pet Diabetes Care Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Pet Diabetes Care Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Pet Diabetes Care Market

• 8.1. Asia-Pacific Pet Diabetes Care Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Pet Diabetes Care Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Pet Diabetes Care Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Pet Diabetes Care Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Pet Diabetes Care Market

• 9.1. China Pet Diabetes Care Market Overview
• 9.2. China Pet Diabetes Care Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Pet Diabetes Care Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Pet Diabetes Care Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Pet Diabetes Care Market

• 10.1. India Pet Diabetes Care Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Pet Diabetes Care Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Pet Diabetes Care Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Pet Diabetes Care Market

• 11.1. Japan Pet Diabetes Care Market Overview
• 11.2. Japan Pet Diabetes Care Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Pet Diabetes Care Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Pet Diabetes Care Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Pet Diabetes Care Market

• 12.1. Australia Pet Diabetes Care Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Pet Diabetes Care Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Pet Diabetes Care Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Pet Diabetes Care Market

• 13.1. Indonesia Pet Diabetes Care Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Pet Diabetes Care Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Pet Diabetes Care Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Pet Diabetes Care Market

• 14.1. South Korea Pet Diabetes Care Market Overview
• 14.2. South Korea Pet Diabetes Care Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Pet Diabetes Care Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Pet Diabetes Care Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Pet Diabetes Care Market

• 15.1. Western Europe Pet Diabetes Care Market Overview
• 15.2. Western Europe Pet Diabetes Care Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Pet Diabetes Care Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Pet Diabetes Care Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Pet Diabetes Care Market

• 16.1. UK Pet Diabetes Care Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Pet Diabetes Care Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Pet Diabetes Care Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Pet Diabetes Care Market

• 17.1. Germany Pet Diabetes Care Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Pet Diabetes Care Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Pet Diabetes Care Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Pet Diabetes Care Market

• 18.1. France Pet Diabetes Care Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Pet Diabetes Care Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Pet Diabetes Care Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Pet Diabetes Care Market

• 19.1. Italy Pet Diabetes Care Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Pet Diabetes Care Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Pet Diabetes Care Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Pet Diabetes Care Market

• 20.1. Spain Pet Diabetes Care Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Pet Diabetes Care Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Pet Diabetes Care Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Pet Diabetes Care Market

• 21.1. Eastern Europe Pet Diabetes Care Market Overview
• 21.2. Eastern Europe Pet Diabetes Care Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Pet Diabetes Care Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Pet Diabetes Care Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Pet Diabetes Care Market

• 22.1. Russia Pet Diabetes Care Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Pet Diabetes Care Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Pet Diabetes Care Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Pet Diabetes Care Market

• 23.1. North America Pet Diabetes Care Market Overview
• 23.2. North America Pet Diabetes Care Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Pet Diabetes Care Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Pet Diabetes Care Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Pet Diabetes Care Market

• 24.1. USA Pet Diabetes Care Market Overview
• 24.2. USA Pet Diabetes Care Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Pet Diabetes Care Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Pet Diabetes Care Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Pet Diabetes Care Market

• 25.1. Canada Pet Diabetes Care Market Overview
• 25.2. Canada Pet Diabetes Care Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Pet Diabetes Care Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Pet Diabetes Care Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Pet Diabetes Care Market

• 26.1. South America Pet Diabetes Care Market Overview
• 26.2. South America Pet Diabetes Care Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Pet Diabetes Care Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Pet Diabetes Care Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Pet Diabetes Care Market

• 27.1. Brazil Pet Diabetes Care Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Pet Diabetes Care Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Pet Diabetes Care Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Pet Diabetes Care Market

• 28.1. Middle East Pet Diabetes Care Market Overview
• 28.2. Middle East Pet Diabetes Care Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Pet Diabetes Care Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Pet Diabetes Care Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Pet Diabetes Care Market

• 29.1. Africa Pet Diabetes Care Market Overview
• 29.2. Africa Pet Diabetes Care Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Pet Diabetes Care Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Pet Diabetes Care Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Pet Diabetes Care Market Competitive Landscape And Company Profiles

• 30.1. Pet Diabetes Care Market Competitive Landscape
• 30.2. Pet Diabetes Care Market Company Profiles
  • 30.2.1. C.H. Boehringer Sohn AG & Co. KG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Zoetis Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Trividia Health Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Pet Diabetes Care Market Other Major And Innovative Companies

• 31.1. Allison Medical Inc.
• 31.2. UltiMed Inc.
• 31.3. Apotex Inc.
• 31.4. Henry Schein VET GmbH
• 31.5. Medtrust Holdings Inc.
• 31.6. i-SENS Inc.
• 31.7. Taidoc Technology Corp.
• 31.8. Covetrus Inc.
• 31.9. ALR Technologies Inc.
• 31.10. Vet Innovations Inc.
• 31.11. F. Hoffmann-La Roche Ltd.
• 31.12. Abbott Laboratories
• 31.13. AgaMatrix Inc.
• 31.14. Ascensia Diabetes Care Holdings AG
• 31.15. Bayer AG

32. Global Pet Diabetes Care Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Pet Diabetes Care Market

34. Recent Developments In The Pet Diabetes Care Market

35. Pet Diabetes Care Market High Potential Countries, Segments and Strategies

• 35.1 Pet Diabetes Care Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Pet Diabetes Care Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Pet Diabetes Care Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer